Quadrovax PFS Vaccine 0.5 ml

Quadrovax PFS Vaccine belongs to the group of medicines called 'immunizing agents' primarily used to prevent diphtheria, pertussis (whooping cough), tetanus, and Haemophilus influenzae type B infection. Diphtheria, Haemophilus influenzae type B infection, pertussis and Tetanus are bacterial infections affecting the nervous system, respiratory tract, and skin. If left untreated, these diseases can be severe and potentially life-threatening. Vaccination is essential to prevent these infections. 

Quadrovax PFS Vaccine contains a combination of Diphtheria toxoid, Tetanus toxoid, Pertussis toxoid and Haemophilus type b conjugate vaccine. It works by introducing a weakened or inactivated form of the disease-causing agent into the body, stimulating the immune system to develop antibodies and antitoxins to fight against the specific disease. Thus, it effectively provides immunity or resistance against these infections without actually triggering the illness.

A healthcare professional will administer Quadrovax PFS Vaccine in a medical setting. You may experience mild side effects, such as redness at the injection site, tenderness, irritability, vomiting, loss of appetite, and fever. Most of these side effects will only last for a few days and resolve on their own. If you notice any persistent and unmanageable side effects, please consult your doctor.

Inform your doctor beforehand if you or your child has a history of severe allergic reactions to vaccines. Also, inform your doctor if your child is taking any other medications or has any pre-existing medical conditions. It should not be given to children with a neurological disorder that is worsening, or those with a family history of brain and nervous system problems, including seizures.

Quadrovax PFS Vaccine is used for the active immunization of infants. The detailed uses of Quadrovax PFS Vaccine are as follows:

• Protects against diphtheria: Quadrovax PFS Vaccine helps build immunity to prevent diphtheria, a serious throat infection.
• Prevents tetanus: Quadrovax PFS Vaccine aids in protecting against tetanus (lockjaw), which causes muscle stiffness and spasms.
• Guards against pertussis: Quadrovax PFS Vaccine provides immunity against whooping cough (pertussis), a contagious respiratory disease.
• Prevents haemophilus influenzae type b infections: Quadrovax PFS Vaccine helps protect against severe infections like meningitis and pneumonia caused by Hib bacteria.

• Quadrovax PFS Vaccine is administered as a four-dose series: a primary three-dose series of a single dose at 2, 4, and 6 months of age and a single booster dose at 15 through 18 months of age.
• Quadrovax PFS Vaccine will be administered by the doctor or healthcare professional.
• Do not self-administer.

Quadrovax PFS Vaccine contains Diphtheria toxoid, Tetanus toxoid, Pertussis toxoid and Haemophilus type b conjugate vaccine. It works by introducing a weakened or inactivated form of the disease-causing agent into the body, stimulating the immune system to develop antibodies and antitoxins to fight against the specific disease. Thus, it effectively provides immunity or resistance against these infections without actually triggering the illness.

Inform your doctor beforehand if you or your child has a history of severe allergic reactions to vaccines. Let your doctor know if your child is taking any other medications or having any pre-existing medical conditions. It should not be given to children with a neurological disorder that is worsening, or those with a family history of brain and nervous system problems, including seizures.